{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:03:30Z","timestamp":1781013810678,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11695-025-08002-4","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:37:32Z","timestamp":1753868252000},"page":"3599-3607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of SGLT2 Inhibitors Use on Risk of Postoperative Acute Kidney Injury Following Metabolic and Bariatric Surgery: A Retrospective Study"],"prefix":"10.1007","volume":"35","author":[{"given":"I-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ning","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"issue":"14","key":"8002_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34339","volume":"10","author":"MR Rajabi","year":"2024","unstructured":"Rajabi MR, et al. Long-term systemic effects of metabolic bariatric surgery: a multidisciplinary perspective. Heliyon. 2024;10(14): e34339.","journal-title":"Heliyon"},{"issue":"6","key":"8002_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.2337\/dc16-0350","volume":"39","author":"DE Cummings","year":"2016","unstructured":"Cummings DE, Cohen RV. Bariatric\/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg\/m2. Diabetes Care. 2016;39(6):924\u201333.","journal-title":"Diabetes Care"},{"issue":"3","key":"8002_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13679-020-00389-8","volume":"9","author":"AE Roth","year":"2020","unstructured":"Roth AE, Thornley CJ, Blackstone RP. Outcomes in bariatric and metabolic surgery: an updated 5-year review. Curr Obes Rep. 2020;9(3):380\u20139.","journal-title":"Curr Obes Rep"},{"issue":"4","key":"8002_CR4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.soard.2024.10.025","volume":"21","author":"K Abi Mosleh","year":"2025","unstructured":"Abi Mosleh K, et al. Assessment of predictors of acute kidney injury and progression to chronic kidney disease following bariatric surgery. Surg Obes Relat Dis. 2025;21(4):382\u20138.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"8002_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11695-012-0766-1","volume":"23","author":"TN Weingarten","year":"2013","unstructured":"Weingarten TN, et al. Acute kidney injury following bariatric surgery. Obes Surg. 2013;23(1):64\u201370.","journal-title":"Obes Surg"},{"issue":"7","key":"8002_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11695-015-1938-6","volume":"26","author":"HR Abdullah","year":"2016","unstructured":"Abdullah HR, et al. Predictors of perioperative acute kidney injury in obese patients undergoing laparoscopic bariatric surgery: a single-centre retrospective cohort study. Obes Surg. 2016;26(7):1493\u20139.","journal-title":"Obes Surg"},{"issue":"3","key":"8002_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/ckj\/sfaa177","volume":"14","author":"J Gameiro","year":"2021","unstructured":"Gameiro J, Marques F, Lopes JA. Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J. 2021;14(3):789\u2013804.","journal-title":"Clin Kidney J"},{"issue":"11","key":"8002_CR8","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow GM, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology. 2005;16(11):3365\u201370.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"8002_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","volume":"16","author":"AJ Scheen","year":"2020","unstructured":"Scheen AJ. Sodium\u2013glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(10):556\u201377.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"8002_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014908","volume":"9","author":"C Arnott","year":"2020","unstructured":"Arnott C, et al. Sodium-glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(3): e014908.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"8002_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","volume":"94","author":"HJL Heerspink","year":"2018","unstructured":"Heerspink HJL, et al. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2018;94(1):26\u201339.","journal-title":"Kidney Int"},{"issue":"2","key":"8002_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/jcp.30621","volume":"237","author":"S Ravindran","year":"2022","unstructured":"Ravindran S, Munusamy S. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. J Cell Physiol. 2022;237(2):1182\u2013205.","journal-title":"J Cell Physiol"},{"issue":"4","key":"8002_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4093\/dmj.2022.0209","volume":"46","author":"NH Kim","year":"2022","unstructured":"Kim NH, Kim NH. Renoprotective mechanism of sodium-glucose cotransporter 2 inhibitors: focusing on renal hemodynamics. Diabetes Metab J. 2022;46(4):543\u201351.","journal-title":"Diabetes Metab J"},{"issue":"5","key":"8002_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/1479164118782872","volume":"15","author":"H Takashima","year":"2018","unstructured":"Takashima H, et al. Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: a randomized open-label prospective trial. Diab Vasc Dis Res. 2018;15(5):469\u201372.","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"8002_CR15","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.clinthera.2023.10.014","volume":"46","author":"R Maxson","year":"2024","unstructured":"Maxson R, et al. SGLT2 inhibitors to slow chronic kidney disease progression: a review. Clin Ther. 2024;46(1):e23\u20138.","journal-title":"Clin Ther"},{"issue":"8","key":"8002_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa2409183","volume":"392","author":"WG Herrington","year":"2025","unstructured":"Herrington WG, et al. Long-term effects of empagliflozin in patients with chronic kidney disease. N Engl J Med. 2025;392(8):777\u201387.","journal-title":"N Engl J Med"},{"issue":"5","key":"8002_CR17","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.kint.2024.08.019","volume":"106","author":"S Miyamoto","year":"2024","unstructured":"Miyamoto S, et al. A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope. Kidney Int. 2024;106(5):972\u201384.","journal-title":"Kidney Int"},{"issue":"12","key":"8002_CR18","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1093\/ndt\/gfae106","volume":"39","author":"P McEwan","year":"2024","unstructured":"McEwan P, et al. The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis. Nephrol Dial Transplant. 2024;39(12):2040\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"8002_CR19","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","volume":"38","author":"RM Goldenberg","year":"2016","unstructured":"Goldenberg RM, et al. SGLT2 inhibitor\u2013associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016;38(12):2654\u20132664.e1.","journal-title":"Clin Ther"},{"key":"8002_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.amsu.2022.104555","volume":"81","author":"A Shafiq","year":"2022","unstructured":"Shafiq A, et al. The dual role of empagliflozin: cardio renal protection in T2DM patients. Annals of Medicine and Surgery. 2022;81:81.","journal-title":"Annals of Medicine and Surgery"},{"key":"8002_CR21","doi-asserted-by":"crossref","unstructured":"Ho CN, et al. Impact of general vs. regional anaesthesia on one\u2010year clinical outcomes and healthcare utilisation after lower limb arthroplasty: a retrospective study. Anaesthesia. 2025;80(5): 488-498.","DOI":"10.1111\/anae.16511"},{"key":"8002_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2024.111574","volume":"98","author":"C-N Ho","year":"2024","unstructured":"Ho C-N, et al. Impact of preoperative QTc interval prolongation on short-term postoperative outcomes: a retrospective study. J Clin Anesth. 2024;98: 111574.","journal-title":"J Clin Anesth"},{"key":"8002_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2025.111811","volume":"103","author":"LIP Snel","year":"2025","unstructured":"Snel LIP, et al. The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: an open-label randomized pilot study. J Clin Anesth. 2025;103: 111811.","journal-title":"J Clin Anesth"},{"issue":"1","key":"8002_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13019-020-01312-x","volume":"15","author":"R Wang","year":"2020","unstructured":"Wang R, et al. The impact of diabetes mellitus on acute kidney injury after coronary artery bypass grafting. J Cardiothorac Surg. 2020;15(1):289.","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"8002_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hbpd.2021.02.006","volume":"20","author":"Y-J Wang","year":"2021","unstructured":"Wang Y-J, et al. Diabetes mellitus is a risk factor of acute kidney injury in liver transplantation patients. Hepatobiliary Pancreat Dis Int. 2021;20(3):215\u201321.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"8002_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8040468","volume":"8","author":"NY Kim","year":"2019","unstructured":"Kim NY, et al. Effect of diabetes mellitus on acute kidney injury after minimally invasive partial nephrectomy: a case-matched retrospective analysis. J Clin Med. 2019;8(4): 468.","journal-title":"J Clin Med"},{"issue":"3","key":"8002_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.4103\/jfmpc.jfmpc_644_21","volume":"11","author":"S Dutta","year":"2022","unstructured":"Dutta S, et al. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: a systematic review and quantitative analysis. Journal of Family Medicine and Primary Care. 2022;11(3):927\u201340.","journal-title":"Journal of Family Medicine and Primary Care"},{"issue":"1","key":"8002_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/biom12010143","volume":"12","author":"C Llorens-Cebri\u00e0","year":"2022","unstructured":"Llorens-Cebri\u00e0 C, et al. Antioxidant roles of SGLT2 inhibitors in the kidney. Biomolecules. 2022;12(1):143.","journal-title":"Biomolecules"},{"key":"8002_CR29","first-page":"53","volume":"22","author":"H Yaribeygi","year":"2023","unstructured":"Yaribeygi H, et al. Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art. Excli J. 2023;22:53\u201366.","journal-title":"Excli J"},{"key":"8002_CR30","doi-asserted-by":"publisher","unstructured":"Tsai KF, et al. Emergence of SGLT2inhibitors as powerful antioxidants in human diseases. Antioxidants (Basel), 2021;10(8):116.\u00a0https:\/\/doi.org\/10.3390\/antiox10081166","DOI":"10.3390\/antiox10081166"},{"issue":"3","key":"8002_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/ALN.0000000000000765","volume":"123","author":"LY Sun","year":"2015","unstructured":"Sun LY, et al. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123(3):515\u201323.","journal-title":"Anesthesiology"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08002-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:41:41Z","timestamp":1758638501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["8002"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08002-4","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}